Rakesh K. Jain will be honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research
The AACR is pleased to announce that Rakesh K. Jain, PhD, FAACR, will be honored with the 2025 AACR Award for Lifetime Achievement in Cancer Research at the AACR Annual Meeting 2025 in Chicago. Dr. Jain is being recognized for his lifelong achievements and pioneering contributions that have transformed the scientific understanding of the tumor microenvironment and its role in cancer progression and treatment. Most notably, his groundbreaking hypothesis of vascular normalization reshaped the use of antiangiogenic therapy and led to FDA-approved drug combinations. Dr. Jain’s visionary integration of engineering and oncology has advanced drug delivery, immunotherapy, and cancer treatment strategies, while his celebrated mentorship and leadership have inspired countless scientists, clinicians, and physician-scientists.
Qualifications
- Lifelong achievements and pioneering contributions in cancer research
- Breakthroughs in understanding the tumor microenvironment and its role in cancer progression and treatment
- Groundbreaking hypothesis of vascular normalization
- Advancements in drug delivery, immunotherapy, and cancer treatment strategies
- Mentorship and leadership that inspire numerous scientists, clinicians, and physician-scientists
Benefits
- Award recognition at the AACR Annual Meeting 2025 in Chicago
- Potential for increased visibility and recognition within the oncology community
Schedule
- Award presentation: Sunday, April 27, 2025, at 3:00 PM Central Time
Pay
- Not specified